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Correction to:  PharmacoEconomics Open (2018) 2:403–413  
https ://doi.org/10.1007/s4166 9-018-0068-1
The Open Access license, which previously read:
Open Access This article is distributed under the terms of 
the Creative Commons Attribution-NonCommercial 4.0 
International License (http://creat iveco mmons .org/licen ses/
by-nc/4.0/), which permits any noncommercial use, distri-
bution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons license, and indicate 
if changes were made.
Should read:
Open Access This article is distributed under the terms of 
the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which per-
mits unrestricted use, distribution, and reproduction in any 
medium, provided you give appropriate credit to the original 
author(s) and the source, provide a link to the Creative Com-
mons license, and indicate if changes were made.
The images or other third party material in this article 
are included in the article’s Creative Commons licence, 
unless indicated otherwise in a credit line to the material. If 
material is not included in the article’s Creative Commons 
licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to 
obtain permission directly from the copyright holder.
To view a copy of this licence, visit http://creat iveco 
mmons .org/licen ses/by/4.0/.
Open Access This article is distributed under the terms of 
the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which per-
mits unrestricted use, distribution, and reproduction in any 
medium, provided you give appropriate credit to the original 
author(s) and the source, provide a link to the Creative Com-
mons license, and indicate if changes were made.
The original article can be found online at https ://doi.org/10.1007/
s4166 9-018-0068-1.
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